Matthew F Covington, John M Hoffman, Kathryn A Morton, Brandon Buckway, Kenneth M Boucher, Regina Rosenthal, Jane Porretta, Kirstyn E Brownson, Cindy B Matsen, Christos Vaklavas, John H Ward, Mei Wei, Saundra S Buys, Namita Chittoria, Ellen D Yakish, Zane G Archibald, Lance D Burrell, Regan I Butterfield, Jeffrey T Yap
Background: PET/CT using 18F-fluoroestradiol (FES) (FDA-approved in 2020) reveals tissues expressing estrogen receptors (ER). Invasive lobular carcinoma (ILC) is commonly ER-positive. Objective: This study's primary aim was to assess the frequency with which sites of histologically proven ILC show abnormal uptake on FES PET/CT. Methods: This prospective single-center pilot study, conducted from December 2020 to August 2021, enrolled patients with histologically confirmed ILC to undergo FES PET/CT; patients optionally underwent FDG PET/CT...
March 15, 2023: AJR. American Journal of Roentgenology